Circulating microRNAs as novel biomarkers of ALK-positive non-small cell lung cancer and predictors of response to crizotinib therapy

Circulating microRNAs are potential diagnostic and predictive biomarkers, but have not been investigated for patients with anaplastic lymphoma kinase (ALK)-positive lung cancer. In this exploratory study, we sought to identify potential plasma biomarkers for ALK-positive non-small cell lung cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Liang-Liang, Qu, Li-Li, Fu, Han-Jiang, Zheng, Xiao-Fei, Tang, Chuan-Hao, Li, Xiao-Yan, Chen, Jian, Wang, Wei-Xia, Yang, Shao-Xing, Wang, Lin, Zhao, Guan-Hua, Lv, Pan-Pan, Zhang, Min, Lei, Yang-Yang, Qin, Hai-Feng, Wang, Hong, Gao, Hong-Jun, Liu, Xiao-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542196/
https://www.ncbi.nlm.nih.gov/pubmed/28514730
http://dx.doi.org/10.18632/oncotarget.17535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542196/
https://www.ncbi.nlm.nih.gov/pubmed/28514730
http://dx.doi.org/10.18632/oncotarget.17535

Ejemplares similares